PSA Vice President Professor Mark Naunton MPS[/caption]
Dr Louise Schaper at PSA25[/caption]
PBS listings for cancer, Parkinson’s and motor neurone disease
Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS).
The...
Experts rank alcohol as the drug which causes the most harm
The public conversation around substance abuse often centres around illicit drugs and prescription medicine misuse, but a new study suggests that the impact of...
Two important new updates to diabetes management
Changes to the National Diabetes Services Scheme (NDSS) now allow more people to access the Continuous Glucose Monitoring (CGM) products available under the scheme...
We must embrace change and lead new models of care
Since becoming National President, I have received significant levels of feedback in support of PSA’s development of pharmacists working in general practice.
I have also...
Collaborate to identify and resolve drug-related problems
An Australian study indicates pharmacists should play a larger role in identifying and resolving drug-related problems (DRPs) as part of a collaborative general practice...
Collaborative prescribing to improve patient outcomes
The results of a study examining collaborative prescribing in Australian hospitals indicates that the practice, already successfully trialled in the US and the UK,...
